Is Tenable Stock a Buy, Sell or Hold?
Tenable (NASDAQ:TENB) is a cybersecurity company with a focus on…
Sell
49
ORI Quote, Financials, Valuation and Earnings
Last price:
$37.62
Seasonality move
:
4.74%
Day range:
$37.40 - $37.90
52-week range:
$28.59 - $39.27
Dividend yield:
2.88%
P/E ratio:
11.62x
P/S ratio:
1.20x
P/B ratio:
1.66x
Volume:
3.1M
Avg. volume:
1.2M
1-year change:
25.76%
Market cap:
$9.3B
Revenue:
$8.2B
EPS (TTM):
$3.24
Analysts' Opinion
-
Consensus RatingOld Republic International has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $40.50, Old Republic International has an estimated upside of 7.6% from its current price of $37.64.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $40.00 representing 100% downside risk from its current price of $37.64.
Fair Value
-
According to the consensus of 1 analyst, Old Republic International has 7.6% upside to fair value with a price target of $40.50 per share.
ORI vs. S&P 500
-
Over the past 5 trading days, Old Republic International has overperformed the S&P 500 by 0.19% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Old Republic International does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Old Republic International has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Old Republic International reported revenues of $2B.
Earnings Growth
-
Old Republic International earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Old Republic International reported earnings per share of $0.42.
Enterprise value:
7.9B
EV / Invested capital:
1.09x
Price / LTM sales:
1.20x
EV / EBIT:
6.88x
EV / Revenue:
0.96x
PEG ratio (5yr expected):
0.21x
EV / Free cash flow:
6.39x
Price / Operating cash flow:
8.02x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
3.09%
Net Income Margin (TTM):
10.36%
Return On Equity:
13.79%
Return On Invested Capital:
10.64%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $8.1B | $7.3B | $8.2B | $1.9B | $2B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $2.29 | $2.10 | $3.24 | $0.69 | $0.42 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $17.3B | $18.1B | $20.2B | $21.5B | $12.4B | |
| Total Assets | $22.8B | $25B | $25.2B | $26.5B | $27.8B | |
| Current Liabilities | $1.1B | $2.2B | $913.8M | $932.4M | $547.5M | |
| Total Liabilities | $16.6B | $18.1B | $19B | $20.1B | $22.2B | |
| Total Equity | $6.2B | $6.9B | $6.2B | $6.4B | $5.6B | |
| Total Debt | $966.4M | $1.6B | $1.6B | $1.6B | $1.6B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.2B | $880.4M | $1.2B | $283.4M | $361.7M | |
| Cash From Investing | -$415M | $25.3M | -$3.9M | -$114.1M | -$45.6M | |
| Cash From Financing | -$832.7M | -$783.2M | -$1.2B | -$117.9M | -$639.2M | |
| Free Cash Flow | $1.2B | $880.4M | $1.2B | $283.4M | $361.7M | |
ORI
Sector
Market Cap
$9.3B
$616.2M
Price % of 52-Week High
95.85%
85.86%
Dividend Yield
2.88%
1.99%
Shareholder Yield
13.38%
3.77%
1-Year Price Total Return
25.76%
8.45%
Beta (5-Year)
0.837
0.714
Dividend yield:
2.88%
Annualized payout:
$1.06
Payout ratio:
31.89%
Growth streak:
1 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$37.29
200-day SMA
Buy
Level
$35.01
Bollinger Bands (100)
Buy
Level
35.38 - 37.82
Chaikin Money Flow
Buy
Level
140.8M
20-day SMA
Buy
Level
$37.38
Relative Strength Index (RSI14)
Buy
Level
55.97
ADX Line
Buy
Level
12
Williams %R
Neutral
Level
-35.2
50-day SMA
Buy
Level
$36.48
MACD (12, 26)
Buy
Level
0.24
25-day Aroon Oscillator
Buy
Level
28
On Balance Volume
Neutral
Level
356.3M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.4649)
Sell
CA Score
(Annual)
Level (-1.4357)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (0.1845)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Old Republic International Corp offers a diverse range of specialized insurance products to individuals and institutions. The company operates in two segments: Specialty Insurance and Title Insurance. The Insurances provided by the company includes Automobile Extended Warranty Insurance, Aviation, Commercial Automobile Insurance, Inland Marine, Travel Accident, Workers' Compensation, Financial Indemnity, and others.
Stock Forecast FAQ
In the current month, ORI has received 0 Buy ratings 1 Hold ratings, and 0 Sell ratings. The ORI average analyst price target in the past 3 months is $40.50.
-
Where Will Old Republic International Stock Be In 1 Year?
According to analysts, the consensus estimate is that Old Republic International share price will rise to $40.50 per share over the next 12 months.
-
What Do Analysts Say About Old Republic International?
Analysts are divided on their view about Old Republic International share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Old Republic International is a Sell and believe this share price will drop from its current level to $40.00.
-
What Is Old Republic International's Price Target?
The price target for Old Republic International over the next 1-year time period is forecast to be $40.50 according to 1 Wall Street analyst, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is ORI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Old Republic International is a Hold. 1 of 1 analysts rates the stock a Hold at this time.
-
How Can I Buy Shares Of ORI?
You can purchase shares of Old Republic International via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Old Republic International shares.
-
What Is The Old Republic International Share Price Today?
Old Republic International was last trading at $37.62 per share. This represents the most recent stock quote for Old Republic International. Yesterday, Old Republic International closed at $37.64 per share.
-
How To Buy Old Republic International Stock Online?
In order to purchase Old Republic International stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is CyberArk Stock a Buy, Sell or Hold?
CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…
Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 20
Regencell Bioscience Holdings [RGC] is down 0% over the past day.
Sell
36
VMI alert for Mar 20
Valmont Industries [VMI] is down 0% over the past day.
Buy
61
ALNY alert for Mar 20
Alnylam Pharmaceuticals [ALNY] is down 0% over the past day.
